Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged ≥50 years

Applied Health Economics and Health Policy

Volumn 11, Issue 3, 2013, Pages 251-258

  Sato, Reiko ^a   Gomez Rey, Gabriel ^b   Nelson, Stephanie ^b   Pinsky, Brett ^b  

^a PFIZER INC   (United States)

^b Health Economics and Outcomes Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BILLING AND CLAIMS; CHRONIC DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; HEALTH CARE COST; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; ICD-9; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PRIVATE HEALTH INSURANCE; RETROSPECTIVE STUDY; RISK; THORAX RADIOGRAPHY; UNITED STATES;

AGED; AGED, 80 AND OVER; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INSURANCE, HEALTH; MALE; MIDDLE AGED; PNEUMONIA; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84878764450     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.1007/s40258-013-0026-0     Document Type: Article

References (29)

1. File TM Jr, Marrie TJ. Burden of community-acquired pneumonia in North American adults. Postgrad Med. 2010;122:130-41.
2. Brar NK, Niederman MS. Management of community-acquired pneumonia: a review and update. Ther Adv Respir Dis. 2011;5:61-78.
3. Metersky ML, Ma A, Houck PM, et al. Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones. Chest. 2007;131:466-73.
4. Marrie TJ, Shariatzadeh MR. Community-acquired pneumonia requiring admission to an intensive care unit: a descriptive study. Medicine (Baltimore). 2007;86:103-11.
5. Restrepo MI, Mortensen EM, Velez JA, et al. A comparative study of community-acquired pneumonia patients admitted to the ward and the ICU. Chest. 2008;133:610-7.
6. Colice GL, Morley MA, Asche C, et al. Treatment costs of community-acquired pneumonia in an employed population. Chest. 2004;125:2140-5.
7. Marrie TJ, Huang JQ. Low-risk patients admitted with community-acquired pneumonia. Am J Med. 2005;118:1357-63.
8. McAlister FA, Majundar SR, Blitz S, et al. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28:810-5.
9. Ewig S, Woodhead M, Torres A. Towards a sensible comprehension of severe community-acquired pneumonia. Intensive Care Med. 2011;37:214-23.
10. Jackson ML, Neuzil KM, Thompson WW, et al. The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis. 2004;39:1642-50.
11. Ramsdell J, Narsavage GL, Fink JB. Management of community-acquired pneumonia in the home. An American College of Chest Physicians Clinical Position Statement. Chest. 2005;127:1752-63.
12. Conte HA, Chen Y-T, Mehal W, et al. A prognostic rule for elderly patients admitted with community-acquired pneumonia. Am J Med. 1999;106:20-8.
13. Stupka JE, Mortensen EM, Anzueto A, et al. Community-acquired pneumonia in elderly patients. Aging Health. 2009;5:763-4.
14. Hall MJ, DeFrances CJ, Williams SN, et al. National Hospital Discharge survey: 2007 summary. National Health Statistics Report Hyattsville, MD: National Center for Health Statistics; 2010. p. 1-21.
15. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44:S27-72.
16. Yu H, Rubin J, Dunning S, Li S, Sato R. Clinical and economic burden of community acquired pneumonia in the Medicare fee-for-service population. J Am Geriatr Soc. 2012;60:2137-43.
17. Bonafede MM, Suava JA, Wilson KL, Mannino DM, Polsky D. Incidence and cost of CAP in a large working-age population. Am J Manag Care. 2012;18:380-7.
18. Martin AB, Lassman D, Washington B, Catlin A, the National Healthcare Expenditure Accounts Team. Growth in US health spending remained slow in 2010; health share of gross domestic product was unchanged from 2009. Health Aff. 2012;31:1208-19.
19. Restrepo MI, Frei CR. Health economics of use of fluoroquinolones to treat patients with community-acquired pneumonia. Am J Med. 2010;123:S39-48.
20. Sun HK, Nicolau DP, Kuti JL. Resource utilization of adults admitted to a large urban hospital with community-acquired pneumonia caused by Streptococcus pneumoniae. Chest. 2006;130:807-14.
21. Orrick JJ, Segal R, Johns TE, et al. Resource use and cost of care for patients hospitalized with community-acquired pneumonia: impact of adherence to Infectious Diseases Society of American guidelines. Pharmacoeconomics. 2004;22:751-7.
22. Restrepo MI, Mortensen EM, Rello J, Brody J, Anzueto A. Late admission to the ICU in patients with community-acquired pneumonia is associated with higher mortality. Chest. 2010;137:552-7.
23. Lindenauer PK, Bernheim SM, Grady NJ, et al. The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for Medicare beneficiaries with pneumonia. J Hosp Med. 2010;5:E13-8.
24. US Department of Labor. Consumer Price Index. Chained Consumer Price Index for all urban consumers (C-CPI-U) 1999-2008. Medical Care Series ID: SUUR0000SAM. Washington, DC: U.S. Dept. of Labor, Bureau of Labor Statistics; 2008.
25. Centers for Disease Control and Prevention. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1997;46:1-24.
26. Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010;59:1102-6.
27. Kaplan V, Angus DC, Griffin M, et al. Hospitalized community-acquired pneumonia in the elderly: age- and sex-related patterns of care and outcome in the United States. Am J Respir Crit Care Med. 2002;165:766-72.
28. DeFrances CJ, Lucas CA, Bule VC, et al. 2006 National Hospital Discharge Survey. Natl Health Stat Rep. 2008;30:1-20.
29. Metlay JP, Fine MJ, Schulz R, et al. Measuring symptomatic and functional recovery in patients with community-acquired pneumonia. J Gen Intern Med. 1997;12:423-30.